Nuvectis Pharma Stock Forward View - Price Action Indicator
| NVCT Stock | USD 8.78 0.04 0.46% |
Nuvectis Stock outlook is based on your current time horizon.
At this time the rsi of Nuvectis Pharma's share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Nuvectis Pharma hype-based prediction, you can estimate the value of Nuvectis Pharma from the perspective of Nuvectis Pharma response to recently generated media hype and the effects of current headlines on its competitors.
Nuvectis Pharma after-hype prediction price | USD 8.69 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Nuvectis Pharma to cross-verify your projections. Nuvectis Pharma Additional Predictive Modules
Most predictive techniques to examine Nuvectis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nuvectis using various technical indicators. When you analyze Nuvectis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.25) | 0.31 |
| Check Nuvectis Pharma Volatility | Backtest Nuvectis Pharma | Information Ratio |
Nuvectis Pharma Trading Date Momentum
| On February 11 2026 Nuvectis Pharma was traded for 8.78 at the closing time. The top price for the day was 8.85 and the lowest listed price was 8.12 . The trading volume for the day was 101.9 K. The trading history from February 11, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.80% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Nuvectis Pharma to competition |
Other Forecasting Options for Nuvectis Pharma
For every potential investor in Nuvectis, whether a beginner or expert, Nuvectis Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Nuvectis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Nuvectis. Basic forecasting techniques help filter out the noise by identifying Nuvectis Pharma's price trends.Nuvectis Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nuvectis Pharma stock to make a market-neutral strategy. Peer analysis of Nuvectis Pharma could also be used in its relative valuation, which is a method of valuing Nuvectis Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Nuvectis Pharma Market Strength Events
Market strength indicators help investors to evaluate how Nuvectis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nuvectis Pharma shares will generate the highest return on investment. By undertsting and applying Nuvectis Pharma stock market strength indicators, traders can identify Nuvectis Pharma entry and exit signals to maximize returns.
| Accumulation Distribution | 8408.53 | |||
| Daily Balance Of Power | 0.0548 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 8.49 | |||
| Day Typical Price | 8.58 | |||
| Price Action Indicator | 0.31 | |||
| Period Momentum Indicator | 0.04 |
Nuvectis Pharma Risk Indicators
The analysis of Nuvectis Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Nuvectis Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nuvectis stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.77 | |||
| Semi Deviation | 2.55 | |||
| Standard Deviation | 3.71 | |||
| Variance | 13.73 | |||
| Downside Variance | 9.23 | |||
| Semi Variance | 6.51 | |||
| Expected Short fall | (3.18) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Nuvectis Pharma
The number of cover stories for Nuvectis Pharma depends on current market conditions and Nuvectis Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nuvectis Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nuvectis Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Nuvectis Pharma Short Properties
Nuvectis Pharma's future price predictability will typically decrease when Nuvectis Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nuvectis Pharma often depends not only on the future outlook of the potential Nuvectis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nuvectis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 17.1 M | |
| Cash And Short Term Investments | 18.5 M |
Additional Tools for Nuvectis Stock Analysis
When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.